Innate Pharma SA Files 6-K Report
Ticker: IPHYF · Form: 6-K · Filed: Apr 10, 2024 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, corporate-info
TL;DR
Innate Pharma SA filed a 6-K on 4/10/24, confirming its French HQ and business classification.
AI Summary
On April 10, 2024, Innate Pharma SA filed a Form 6-K, reporting its status as a foreign private issuer. The filing confirms the company's principal executive office is located at 117 Avenue de Luminy, BP 30191, 13009 Marseille, France. Innate Pharma SA is listed under the SIC code 2836 for Biological Products (No Diagnostic Substances).
Why It Matters
This filing provides essential corporate information and confirms the company's operational base and classification for regulatory purposes.
Risk Assessment
Risk Level: low — This is a routine filing providing basic corporate information and does not contain material financial or operational updates.
Key Numbers
- 001-39084 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- 001-39084 (company) — Commission File Number
- 2836 (company) — Standard Industrial Classification Code
- April 10, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically confirming the company's status as a foreign private issuer and providing its principal executive office details.
Where is Innate Pharma SA's principal executive office located?
Innate Pharma SA's principal executive office is located at 117 Avenue de Luminy—BP 30191, 13009 Marseille, France.
What is Innate Pharma SA's Standard Industrial Classification (SIC) code?
Innate Pharma SA's SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Does Innate Pharma SA file annual reports under Form 20-F or Form 40-F?
Innate Pharma SA indicates that it files annual reports under cover of Form 20-F.
What is the Commission File Number for Innate Pharma SA?
The Commission File Number for Innate Pharma SA is 001-39084.
Filing Stats: 206 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2024-04-10 06:51:29
Filing Documents
- a240410-6k.htm (6-K) — 9KB
- exhibit991-240410.htm (EX-99.1) — 16KB
- 0001598599-24-000023.txt ( ) — 26KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date April 10, 2024 By s HERVE BRAILLY Name Herv Brailly Title Chairman of the Executive Board and Chief Executive Officer